Priya Nair appointed new CEO and MD of Hindustan Unilever, to succeed Rohit Jawa

Microsoft's Cindy Rose to succeed Mark Read as WPP CEO

‘Sham’, ‘scam’: Cannes Lions-award winning ads under public scrutiny

30% surge in footfalls, 40% repeat fans, why India's concert economy is exploding

Digital Entertainment Summit 2025: The Highlights

Nobody’s Perfect Retro Porsche Ad

In Conversation With Raja Rajamannar, Mastercard

Shahid Kapoor And Varun Ganjoo Speaks On PokerBaazi's Campaign

In conversation with IHCL’s Puneet Chhatwal & GroupM’s Kate Scott-Dawkins

Why are brands including e-sports in their sports marketing itinerary?

Storyboard18 x The English Nut: How to pronounce these 10 brand names

Experts' Take On Reinvention Of Ad Campaigns Through Technology

Experts Speak On Key Emerging Trends In Cannes Lions Entries

Leaders of the future have to be outstanding human beings: Nestle MD

In conversation with VMLY&R’s Hari Ramanathan

The Supreme Court has recommended that the Ministry of AYUSH create a centralized dashboard to publicize and track complaints against misleading advertisements related to medicinal or allied healthcare products.

The suggestion came from a bench comprising Justices Hima Kohli and Sandeep Mehta, who observed challenges in monitoring the progress of these complaints.

"We believe the Ministry of AYUSH should establish a dashboard displaying complaints received from stakeholders and state licensing authorities to make the data publicly accessible. This would also address the issue where prosecutions under the Drugs and Cosmetics Act are hindered due to the lack of complaints," the Court stated on Tuesday.

The Court was hearing a case filed by the Indian Medical Association (IMA) against Patanjali Ayurved and its promoters, Baba Ramdev and Acharya Balkrishna, for publishing misleading advertisements about allopathic medicine.

Advocate Shadan Farasat was appointed as amicus curiae to assist the Court by compiling data submitted by various states and regulatory authorities.

The scope of the case has since expanded beyond the alleged misconduct by Patanjali to encompass broader issues, such as misleading advertisements by other entities, the liability of celebrity influencers endorsing misleading ads, and unethical practices in modern medicine.

Create centralized dashboard, publicize complaints against misleading ads: SC to Ministry of Ayush

PATANJALI